[1]
Sangar, V.C. et al. 2015. POST-MARKETING PASSIVE SURVEILLANCE OFBIVALENT AND QUADRIVALENT HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINES. International Journal of Pharmacy and Pharmaceutical Sciences. 7, 4 (Apr. 2015), 393–397.